+1-888-308-5802     
News Contact Us

IMS subsidiary rolls out blockchain-powered organic platform in China

Author : Pankaj Singh | Published Date : 2019-10-15 

A booming middle-class population in China along with changing consumer outlook towards heathy lifestyle indicates immense potential for the organic market in the region to grow. Analysts claim that China’s middle class will account for more than one-third of its population by 2030 which will open up great new opportunities for digital shopping platform developers.

The country’s blockchain technology is already dominating the global market. Online shopping platform designers are exploring ways to incorporate the technology to provide novel and innovative solutions to customers.

IMS Digital Ventures, a venture capital subsidiary of the HongKong-based Integrated Management Systems (IMS), recently unveiled a social and content platform in China called OrgHive that will seemingly allow consumers to make a right purchasing-decision and differentiate between authentic organic products through real-time database authentication using blockchain technology.

Apparently, the inability of consumers to distinguish between authentic organic products and lack of objective information on the benefits of these products has proved to be a challenge for brands conducting business in China.

OrgHive’s comprehensive AI algorithm evidently allows brands to efficiently target, engage, and convert audiences. Increased transparency and effective marketing will further enable brands to penetrate the Chinese market.

In addition to verifying the authenticity of organic products, the platform will supposedly enable users to post reviews, share content, follow brands, and build their followers.

Sources with relevant information reported that the platform will provide companies with direct access to users through appropriate and careful interaction. Brands looking to join the platform can create their own microsite from which they can grow their following, send push notifications, and drive consumers to e-commerce platforms.

The platform provides a unique and exciting opportunity to foster the future of the Chinese organic market, mentioned CEO Anastasios Papadopoulos, adding that the platform will offer brands an effective and transparent to reach and engage customers on a highly opaque and digital landscape.

By delivering detailed insights to brands based on platform analytics and user behavior, the company is transforming China’s smart shopping landscape, noted Papadopoulos.

Sources Credits –  https://www.businesswire.com/news/home/20191013005041/en/Venture-Capital-Arm-Asia%E2%80%99s-Leading-Digital-Agency

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Sir Richard Branson to contribute £200M to stabilize Virgin Atlantic

Published Date: 2020-07-14         Author: Pankaj Singh

British business magnate Sir Richard Branson had reportedly announced that he intends to contribute a sum of £200 million as part of the £1 billion plan to stabilize Virgin Atlantic without taxpayers’ money. Sources state that he will use the funds raised by selling a £396 mi... Read More

The Electric Cycle Company announces plans to move to bigger premises

Published Date: 2020-07-13         Author: Pankaj Singh

After a successful launch of a £70,000 crowdfunding campaign to renovate its shop and workshop, the Scottish e-bike firm Electric Cycle Company has reportedly announced its plans to move to a 4000 sq. ft., carbon-neutral Edinburgh-based premise, which will be the largest e-bike shop in the UK.... Read More

Cipla launches generic version of Remdesivir at a price of ₹4,000

Published Date: 2020-07-10         Author: Pankaj Singh

Cipla Limited, the multinational pharmaceutical company, has reportedly launched a generic version of the remdesivir drug (Cipremi) at a price of ?4,000 per 100 mg vial, making it among the least priced COVID-19 treatment available across the globe. According to sources familiar with the knowledg... Read More

© 2020 Fractovia. All Rights Reserved